MXCT - MaxCyte, Inc.
About MaxCyte, Inc. (https://maxcyte.com)
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Maher Masoud | President, Chief Executive Officer & Executive Director | 1976 | $919,082 USD |
| Douglas J. Swirsky | Chief Financial Officer | 1969 | $700,557 USD |
| Parmeet Ahuja | Chief Financial Officer | 1969 | $700,557 USD |
| Ana-Paula Martins Fernandes | Senior Vice President of Global Sales | – | – |
| Jack Horgan | Senior Vice President of Corporate Development | – | – |
| Jay Gelfman | Chief Operations Officer | – | – |
| Jill Mayer | Senior Vice President of Human Resources | – | – |